1. Chung FP, Lin YJ, Chang SL, et al. Long-term follow-up of catheter ablation of ventricular arrhythmias: experiences from a tertiary referral center in Taiwan. Acta Cardiol Sin. 2015; 31:8–17.
2. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010; 31:806–814.
3. Chung FP, Lin YJ, Chang SL, et al. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiol. 2015; 65:441–450.
4. Mori M, Kitagawa T, Sasaki Y, et al. Long-term survival of a patient with multiple myeloma-associated severe cardiac AL amyloidosis after implantation of a cardioverter-defibrillator. Rinsho Ketsueki. 2014; 55:450–455.
5. Frankel DS, Mountantonakis SE, Zado ES, et al. Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence. J Am Coll Cardiol. 2012; 59:1529–1535.
6. Sacher F, Lim HS, Derval N, et al. Substrate mapping and ablation for ventricular tachycardia: the LAVA approach. J Cardiovasc Electrophysiol. 2015; 26:464–471.